Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co LtdfiledCriticalKaken Pharmaceutical Co Ltd
Priority to JP2603084ApriorityCriticalpatent/JPS60172919A/ja
Publication of JPS60172919ApublicationCriticalpatent/JPS60172919A/ja
Publication of JPH0419965B2publicationCriticalpatent/JPH0419965B2/ja
Nouveaux composes agonistes du recepteur h 3? de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation.